DRTECH Corporation (214680) - Net Assets

Latest as of September 2025: ₩76.77 Billion KRW ≈ $52.03 Million USD

Based on the latest financial reports, DRTECH Corporation (214680) has net assets worth ₩76.77 Billion KRW (≈ $52.03 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩208.66 Billion ≈ $141.40 Million USD) and total liabilities (₩131.88 Billion ≈ $89.38 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DRTECH Corporation (214680) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩76.77 Billion
% of Total Assets	36.79%
Annual Growth Rate	13.04%
5-Year Change	119.87%
10-Year Change	N/A
Growth Volatility	20.4

DRTECH Corporation - Net Assets Trend (2016–2024)

This chart illustrates how DRTECH Corporation's net assets have evolved over time, based on quarterly financial data. Also explore 214680 total assets for the complete picture of this company's asset base.

Annual Net Assets for DRTECH Corporation (2016–2024)

The table below shows the annual net assets of DRTECH Corporation from 2016 to 2024. For live valuation and market cap data, see DRTECH Corporation (214680) market capitalisation.

Year	Net Assets	Change
2024-12-31	₩72.77 Billion ≈ $49.32 Million	-13.97%
2023-12-31	₩84.59 Billion ≈ $57.33 Million	+40.11%
2022-12-31	₩60.38 Billion ≈ $40.92 Million	+36.86%
2021-12-31	₩44.11 Billion ≈ $29.90 Million	+33.28%
2020-12-31	₩33.10 Billion ≈ $22.43 Million	-11.41%
2019-12-31	₩37.36 Billion ≈ $25.32 Million	+19.25%
2018-12-31	₩31.33 Billion ≈ $21.23 Million	+18.20%
2017-12-31	₩26.50 Billion ≈ $17.96 Million	-2.91%
2016-12-31	₩27.30 Billion ≈ $18.50 Million	--

Equity Component Analysis

This analysis shows how different components contribute to DRTECH Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 554.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	₩7.90 Billion	10.86%
Other Components	₩84.86 Billion	116.61%
Total Equity	₩72.77 Billion	100.00%

DRTECH Corporation Competitors by Market Cap

The table below lists competitors of DRTECH Corporation ranked by their market capitalization.

Company	Market Cap
seha corporation KO:027970	$98.45 Million
Sound Financial Bancorp Inc NASDAQ:SFBC	$98.53 Million
Bioton S.A. WAR:BIO	$98.54 Million
Yuen Chang Stainless Steel Co Ltd TW:2069	$98.55 Million
ABC Taiwan Electronics TWO:3236	$98.42 Million
Agile Group Holdings Limited F:A8P	$98.38 Million
Ekter SA AT:EKTER	$98.38 Million
Genovate Biotechnology Co Ltd TWO:4130	$98.37 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in DRTECH Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 84,568,479,560 to 72,773,225,510, a change of -11,795,254,050 (-13.9%).
Net loss of 19,289,549,660 reduced equity.
Dividend payments of 500,000 reduced retained earnings.
Share repurchases of 1,321,602,050 reduced equity.
New share issuances of 1,321,602,050 increased equity.
Other factors increased equity by 7,494,795,610.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	₩-19.29 Billion	-26.51%
Dividends Paid	₩500.00K	-0.0%
Share Repurchases	₩1.32 Billion	-1.82%
Share Issuances	₩1.32 Billion	+1.82%
Other Changes	₩7.49 Billion	+10.3%
Total Change	₩-	-13.95%

Book Value vs Market Value Analysis

This analysis compares DRTECH Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.93x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 2.80x to 1.93x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩677.92	₩1900.00	x
2017-12-31	₩641.33	₩1900.00	x
2018-12-31	₩708.62	₩1900.00	x
2019-12-31	₩762.81	₩1900.00	x
2020-12-31	₩639.17	₩1900.00	x
2021-12-31	₩779.06	₩1900.00	x
2022-12-31	₩1040.60	₩1900.00	x
2023-12-31	₩1168.24	₩1900.00	x
2024-12-31	₩983.22	₩1900.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently DRTECH Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -26.51%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -19.77%
• Asset Turnover: 0.54x
• Equity Multiplier: 2.46x
Recent ROE (-26.51%) is below the historical average (-3.77%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2016	-1.60%	-1.19%	0.97x	1.38x	₩-3.17 Billion
2017	-6.85%	-4.68%	0.89x	1.64x	₩-4.47 Billion
2018	3.98%	2.79%	0.90x	1.59x	₩-1.89 Billion
2019	2.53%	1.97%	0.67x	1.90x	₩-2.79 Billion
2020	-21.85%	-13.08%	0.60x	2.77x	₩-10.54 Billion
2021	9.15%	5.75%	0.75x	2.13x	₩-373.34 Million
2022	9.89%	6.67%	0.74x	2.00x	₩-65.46 Million
2023	-2.66%	-2.43%	0.56x	1.94x	₩-10.71 Billion
2024	-26.51%	-19.77%	0.54x	2.46x	₩-26.57 Billion

Industry Comparison

This section compares DRTECH Corporation's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $111,759,995,438
Average return on equity (ROE) among peers: -4.35%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
DRTECH Corporation (214680)	₩76.77 Billion	-1.60%	1.72x	$98.45 Million
Shinhung (004080)	$77.28 Billion	1.29%	0.82x	$88.63 Million
HansBiomed Corporation (042520)	$33.89 Billion	-92.49%	2.73x	$258.75 Million
JVM Co. Ltd (054950)	$104.90 Billion	4.97%	0.55x	$195.14 Million
Huvitz Co. Ltd (065510)	$78.68 Billion	3.95%	0.79x	$58.02 Million
Vieworks Co. Ltd (100120)	$126.17 Billion	15.56%	0.09x	$165.07 Million
Corentec Co Ltd (104540)	$60.18 Billion	0.77%	0.59x	$50.52 Million
Humasis Co. Ltd (205470)	$346.73 Billion	52.67%	0.35x	$61.42 Million
NH SPAC 2 (206640)	$151.09 Billion	29.36%	0.27x	$169.86 Million
Hana Must SPAC 2 (208370)	$26.92 Billion	-55.25%	0.69x	$75.64 Million

About DRTECH Corporation

KQ:214680 Korea Medical Devices

Market Cap

$98.45 Million

₩145.27 Billion KRW

Market Cap Rank

#19240 Global

#1042 in Korea

Share Price

₩1900.00

Change (1 day)

-0.16%

52-Week Range

₩1576.00 - ₩2275.00

All Time High

₩7140.00